| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Aberrant proteomic expression of NSRP70 and its clinical implications and connection to the transcriptional level in adult acute leukemia
|
Choi, Dan-Bee
|
|
2014
|
38 |
10 |
p. 1252-1259
8 p.
|
artikel
|
| 2 |
Age influences initial dose and compliance to imatinib in chronic myeloid leukemia elderly patients but concomitant comorbidities appear to influence overall and event-free survival
|
Breccia, Massimo
|
|
2014
|
38 |
10 |
p. 1173-1176
4 p.
|
artikel
|
| 3 |
Allergy and risk of hematologic malignancies: Associations and mechanisms
|
Musolino, C.
|
|
2014
|
38 |
10 |
p. 1137-1144
8 p.
|
artikel
|
| 4 |
An improved recombinant Fab-immunotoxin targeting CD22 expressing malignancies
|
Bera, Tapan K.
|
|
2014
|
38 |
10 |
p. 1224-1229
6 p.
|
artikel
|
| 5 |
A paradigm for cybernetics, regulatory circuits and ultra-stability in cancer biology and treatment
|
Staege, Martin S.
|
|
2014
|
38 |
10 |
p. 1158-1159
2 p.
|
artikel
|
| 6 |
Chronic lymphocytic leukaemia cells become both activated and immunosuppressive following interaction with CD3 and CD28 stimulated PBMC
|
Hock, B.D.
|
|
2014
|
38 |
10 |
p. 1217-1223
7 p.
|
artikel
|
| 7 |
Clinical significance of microcytosis in patients with primary myelofibrosis
|
Strati, Paolo
|
|
2014
|
38 |
10 |
p. 1212-1216
5 p.
|
artikel
|
| 8 |
CLL—Clear sailing ahead for many, while rough waters remain for some
|
Toze, Cynthia L.
|
|
2014
|
38 |
10 |
p. 1154-1155
2 p.
|
artikel
|
| 9 |
Editorial board and publication information
|
|
|
2014
|
38 |
10 |
p. IFC-
1 p.
|
artikel
|
| 10 |
Elderly CML patients’ treatment: Considering not only physician's judgment but also co-morbidity indexes
|
Sánchez-Guijo, Fermín
|
|
2014
|
38 |
10 |
p. 1156-1157
2 p.
|
artikel
|
| 11 |
Erythrocyte membrane fatty acids in multiple myeloma patients
|
Jurczyszyn, Artur
|
|
2014
|
38 |
10 |
p. 1260-1265
6 p.
|
artikel
|
| 12 |
Familial systemic mastocytosis with germline KIT K509I mutation is sensitive to treatment with imatinib, dasatinib and PKC412
|
de Melo Campos, Paula
|
|
2014
|
38 |
10 |
p. 1245-1251
7 p.
|
artikel
|
| 13 |
Genomic aberrations deletion 11q and deletion 17p independently predict for worse progression-free and overall survival after allogeneic hematopoietic cell transplantation for chronic lymphocytic leukemia
|
Chavez, Julio C.
|
|
2014
|
38 |
10 |
p. 1165-1172
8 p.
|
artikel
|
| 14 |
Interferon α-2b gains high sustained response therapy for advanced essential thrombocythemia and polycythemia vera with JAK2V617F positive mutation
|
Huang, Bin-Tao
|
|
2014
|
38 |
10 |
p. 1177-1183
7 p.
|
artikel
|
| 15 |
LIFRα-CT3 induces differentiation of a human acute myelogenous leukemia cell line HL-60 by suppressing miR-155 expression through the JAK/STAT Pathway
|
Xu, Sha
|
|
2014
|
38 |
10 |
p. 1237-1244
8 p.
|
artikel
|
| 16 |
Outcome prediction by the transcript level of BCR-ABL at 3 months in patients with chronic myeloid leukemia treated with imatinib-a single institution historical experience
|
Yin, Xiu-Feng
|
|
2014
|
38 |
10 |
p. 1191-1198
8 p.
|
artikel
|
| 17 |
Prognostic impact of splenomegaly on survival of Chinese with primary myelofibrosis
|
Wang, Jingya
|
|
2014
|
38 |
10 |
p. 1207-1211
5 p.
|
artikel
|
| 18 |
Results of allogeneic stem cell transplantation in the Spanish MDS registry: Prognostic factors for low risk patients
|
Díez Campelo, M.
|
|
2014
|
38 |
10 |
p. 1199-1206
8 p.
|
artikel
|
| 19 |
Subcutaneous omacetaxine mepesuccinate in patients with chronic myeloid leukemia in tyrosine kinase inhibitor-resistant patients: Review and perspectives
|
Heiblig, M.
|
|
2014
|
38 |
10 |
p. 1145-1153
9 p.
|
artikel
|
| 20 |
The passive–aggressive relationship between CLL-B cells and T cell immunity
|
Davis, Joanne E.
|
|
2014
|
38 |
10 |
p. 1160-1161
2 p.
|
artikel
|
| 21 |
The platelet–cancer loop in myeloproliferative cancer. Is thrombocythemia an enhancer of cancer invasiveness and metastasis in essential thrombocythemia, polycythemia vera and myelofibrosis?
|
Hasselbalch, Hans Carl
|
|
2014
|
38 |
10 |
p. 1230-1236
7 p.
|
artikel
|
| 22 |
The prognostic importance of polypharmacy in older adults treated for acute myelogenous leukemia (AML)
|
Elliot, Kathleen
|
|
2014
|
38 |
10 |
p. 1184-1190
7 p.
|
artikel
|
| 23 |
Why is there so much therapy-related AML and MDS and so little therapy-related CML?
|
Gale, Robert Peter
|
|
2014
|
38 |
10 |
p. 1162-1164
3 p.
|
artikel
|
Tijdschrift beschrijving